フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
SOUTH SAN FRANCISCO, Calif., Sept. 7 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. (NASDAQ:MGRM), formerly ViroLogic, Inc., announced...
Conference Call Scheduled for 4:30 p.m. Eastern Today SO. SAN FRANCISCO, Calif., Sept. 6 /PRNewswire-FirstCall/ -- ViroLogic, Inc...
SOUTH SAN FRANCISCO, Calif., Sept. 1 /PRNewswire-FirstCall/ -- ViroLogic, Inc. (NASDAQ:VLGC) today announced the appointment of William J. Welch...
ViroLogic Announces Second Quarter 2005 Financial Results Conference Call SOUTH SAN FRANCISCO, Calif., July 19 /PRNewswire-FirstCall/...
ViroLogic Announces Second Quarter 2005 Financial Results - HIV clinical trials provide boost to testing revenues - 35% revenue growth - SOUTH SAN...
ViroLogic Announces Multi-Year Service Agreement With Schering-Plough to Support New HIV Drug Discovery and Development Efforts SOUTH SAN...
ViroLogic to Present at Pacific Growth Equities 2005 Life Sciences Growth Conference SO. SAN FRANCISCO, Calif., May 31 /PRNewswire-FirstCall/...
ViroLogic Added to the NASDAQ Biotechnology Index SOUTH SAN FRANCISCO, Calif., May 20 /PRNewswire-FirstCall/ -- ViroLogic, Inc. (NASDAQ:VLGC...
ViroLogic's eTag System Demonstrates Potential Ability to Better Select Breast Cancer Patients for Therapy With Herceptin -Abstract #553...
Study Demonstrates ViroLogic's eTag System Can Measure Activated VEGF Receptor, Target for Anti-Angiogenic Treatments -Abstract #9595- ORLANDO...
Semi-Annual Changes to the NASDAQ Biotechnology Index NEW YORK, May 13 /PRNewswire-FirstCall/ -- The Nasdaq Stock Market, Inc. ("NASDAQ...
ViroLogic Announces Presentations on Its eTag Technology at the 2005 American Society of Clinical Oncology Annual Meeting (ASCO) SOUTH SAN...
ViroLogic Announces First Quarter 2005 Financial Results Conference Call SOUTH SAN FRANCISCO, Calif., April 26 /PRNewswire-FirstCall/...
ViroLogic Announces First Quarter 2005 Financial Results - Progress with oncology clinical studies and HIV pharmaceutical testing SOUTH SAN...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約